• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于局部麻醉镇痛治疗的利多卡因和丙胺卡因共载纳米颗粒药物递送系统的设计与评价:固体脂质纳米粒与纳米结构脂质载体的比较

Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.

作者信息

You Peijun, Yuan Ran, Chen Chuanyu

机构信息

Department of Anesthesiology, Shandong Jining No 1 People's Hospital, Shandong, People's Republic of China.

Department of Anesthesiology, Affiliated Hospital of Jining Medical College, Jining, Shandong, People's Republic of China.

出版信息

Drug Des Devel Ther. 2017 Sep 18;11:2743-2752. doi: 10.2147/DDDT.S141031. eCollection 2017.

DOI:10.2147/DDDT.S141031
PMID:29075099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5609786/
Abstract

PURPOSE

Topical anesthesia analgesic therapy has diverse applicability in solving the barrier properties of skin and unfavorable physicochemical properties of drugs. Lidocaine (LID) combined with prilocaine (PRI) has been used as a topical preparation for dermal anesthesia for treatment of conditions such as paresthesia.

MATERIALS AND METHODS

In this study, for combination anesthesia and overcoming the drawbacks of LID and PRI, respectively, LID- and PRI-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) were prepared and characterized by determination of their particle size, drug loading capacity, stability, in vitro drug release behavior and in vitro cellular viability. Ex vivo skin permeation and in vivo anesthesia analgesic efficiency of these two systems were also evaluated and compared.

RESULTS

Results revealed that combination delivery of the dual drugs exhibited more remarkable efficiency than signal drug-loaded systems. SLN systems have better ex vivo skin permeation ability than NLCs. NLC systems revealed a stronger in vivo anesthesia analgesic effect than SLN systems.

CONCLUSION

It can be concluded that SLNs and NLCs have different advantages, and that both carriers are promising dual drug delivery systems for topical anesthetic analgesic therapy.

摘要

目的

局部麻醉镇痛疗法在解决皮肤屏障特性和药物不良理化性质方面具有多种适用性。利多卡因(LID)与丙胺卡因(PRI)联合使用已被用作皮肤麻醉的局部制剂,用于治疗感觉异常等病症。

材料与方法

在本研究中,为了分别实现联合麻醉并克服利多卡因和丙胺卡因的缺点,制备了负载利多卡因和丙胺卡因的固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC),并通过测定其粒径、载药量、稳定性、体外药物释放行为和体外细胞活力对其进行表征。还评估并比较了这两种体系的离体皮肤渗透和体内麻醉镇痛效果。

结果

结果表明,两种药物的联合递送比单药负载体系表现出更显著的效果。SLN体系比NLC体系具有更好的离体皮肤渗透能力。NLC体系比SLN体系表现出更强的体内麻醉镇痛作用。

结论

可以得出结论,SLN和NLC具有不同的优势,并且这两种载体都是用于局部麻醉镇痛治疗的有前景的双药递送体系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/0fa3d2427fb9/dddt-11-2743Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/d28970811e2b/dddt-11-2743Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/78339bc522b4/dddt-11-2743Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/de71165e211d/dddt-11-2743Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/a55c0607edae/dddt-11-2743Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/0fa3d2427fb9/dddt-11-2743Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/d28970811e2b/dddt-11-2743Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/78339bc522b4/dddt-11-2743Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/de71165e211d/dddt-11-2743Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/a55c0607edae/dddt-11-2743Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448c/5609786/0fa3d2427fb9/dddt-11-2743Fig5.jpg

相似文献

1
Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.用于局部麻醉镇痛治疗的利多卡因和丙胺卡因共载纳米颗粒药物递送系统的设计与评价:固体脂质纳米粒与纳米结构脂质载体的比较
Drug Des Devel Ther. 2017 Sep 18;11:2743-2752. doi: 10.2147/DDDT.S141031. eCollection 2017.
2
Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.转录激活肽修饰的利多卡因载药纳米给药系统用于局部麻醉治疗。
Drug Deliv. 2016 Nov;23(9):3193-3199. doi: 10.3109/10717544.2016.1160459. Epub 2016 Apr 5.
3
Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.使用载利多卡因的纳米结构脂质载体的局部麻醉疗法:生育酚聚乙二醇1000琥珀酸酯修饰的透皮给药系统。
Drug Des Devel Ther. 2018 Dec 13;12:4231-4240. doi: 10.2147/DDDT.S187177. eCollection 2018.
4
Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.利多卡因通过包封于纳米脂质体和纳米结构脂质载体中增强皮肤渗透:一项比较研究。
Pharmazie. 2016 May;71(5):247-51.
5
Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.局部麻醉药利多卡因递送系统:壳聚糖和透明质酸修饰的层层脂质纳米颗粒
Drug Deliv. 2016 Nov;23(9):3529-3537. doi: 10.1080/10717544.2016.1204569. Epub 2016 Jul 17.
6
Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo.长期麻醉镇痛效果:载有盐酸丁卡因的聚合物纳米粒、固体脂质纳米粒和纳米结构脂质载体的体外和体内比较。
Biomed Pharmacother. 2019 Sep;117:109057. doi: 10.1016/j.biopha.2019.109057. Epub 2019 Jun 14.
7
Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.使用罗哌卡因和右美托咪定联合的局部麻醉镇痛疗法:含有皮肤渗透促进剂的透明质酸修饰长效纳米结构脂质载体。
Drug Des Devel Ther. 2019 Sep 18;13:3307-3319. doi: 10.2147/DDDT.S211443. eCollection 2019.
8
Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.利多卡因脂质纳米系统的构建与评价及其经皮给药
AAPS PharmSciTech. 2009;10(3):985-92. doi: 10.1208/s12249-009-9287-1. Epub 2009 Jul 30.
9
Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers.经渗透促进剂和转录转激活肽多修饰的纳米结构脂质载体的局部麻醉和止痛作用。
Drug Deliv. 2021 Dec;28(1):478-486. doi: 10.1080/10717544.2021.1889717.
10
Sustained delivery of prilocaine and lidocaine using depot microemulsion system: and animal studies.利用储库型微乳系统持续释放普鲁卡因和利多卡因: 和 动物研究。
Drug Dev Ind Pharm. 2020 Feb;46(2):264-271. doi: 10.1080/03639045.2020.1716377. Epub 2020 Jan 30.

引用本文的文献

1
Review on Electrospray Nanoparticles for Drug Delivery: Exploring Applications.用于药物递送的电喷雾纳米颗粒综述:探索应用
Polym Adv Technol. 2024 Jul;35(7). doi: 10.1002/pat.6507. Epub 2024 Jul 16.
2
Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause?纳米医学与电压门控钠离子通道阻滞剂在疼痛管理中的应用:改变游戏规则还是错失良机?
Drug Deliv Transl Res. 2024 Aug;14(8):2112-2145. doi: 10.1007/s13346-024-01615-9. Epub 2024 Jun 11.
3
Advances in the use of local anesthetic extended-release systems in pain management.

本文引用的文献

1
A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.一种新型局部麻醉系统:用于罗哌卡因经皮递送的转录激活因子肽修饰纳米载体
Drug Des Devel Ther. 2017 Jun 28;11:1941-1949. doi: 10.2147/DDDT.S135916. eCollection 2017.
2
Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.淋巴癌化疗:通过纳米结构脂质载体递送阿霉素-吉西他滨前药和长春新碱。
Int J Nanomedicine. 2017 Feb 27;12:1565-1576. doi: 10.2147/IJN.S120685. eCollection 2017.
3
Nanoliposome encapsulated anesthetics for local anesthesia application.
局部麻醉药控释系统在疼痛管理中的应用进展。
Drug Deliv. 2024 Dec;31(1):2296349. doi: 10.1080/10717544.2023.2296349. Epub 2023 Dec 21.
4
Application of Advanced Technologies-Nanotechnology, Genomics Technology, and 3D Printing Technology-In Precision Anesthesia: A Comprehensive Narrative Review.先进技术(纳米技术、基因组学技术和3D打印技术)在精准麻醉中的应用:一篇全面的叙述性综述
Pharmaceutics. 2023 Sep 6;15(9):2289. doi: 10.3390/pharmaceutics15092289.
5
An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.纳米结构脂质载体概述及其在不同给药途径中的药物递送应用。
Adv Pharm Bull. 2023 Jul;13(3):446-460. doi: 10.34172/apb.2023.056. Epub 2022 Sep 18.
6
Pharmacological Evaluation of the Anesthetic and Analgesic Potential of Injection Harsha 22: A Novel Polyherbal Local Anesthetic Formulation Intended for Parenteral Administration in Wistar Albino Rats.注射用Harsha 22麻醉和镇痛潜力的药理学评估:一种旨在用于Wistar白化大鼠肠胃外给药的新型多草药局部麻醉制剂
J Exp Pharmacol. 2023 Mar 27;15:149-161. doi: 10.2147/JEP.S402277. eCollection 2023.
7
Recent advances in pain management based on nanoparticle technologies.基于纳米颗粒技术的疼痛管理新进展。
J Nanobiotechnology. 2022 Jun 18;20(1):290. doi: 10.1186/s12951-022-01473-y.
8
Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers and .联合麻醉疗法:使用转录激活肽修饰的纳米结构脂质载体共递送罗哌卡因和美洛昔康。
Drug Deliv. 2022 Dec;29(1):263-269. doi: 10.1080/10717544.2021.2023695.
9
Comparing the Effect of Lidocaine-Prilocaine Cream and Infiltrative Lidocaine on Overall Pain Perception During Thoracentesis and Abdominocentesis: A Randomized Clinical Trial.比较利多卡因-丙胺卡因乳膏与浸润性利多卡因对胸腔穿刺术和腹腔穿刺术期间总体疼痛感知的影响:一项随机临床试验。
Anesth Pain Med. 2020 Nov 18;11(1):e106275. doi: 10.5812/aapm.106275. eCollection 2021 Feb.
10
Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers.经渗透促进剂和转录转激活肽多修饰的纳米结构脂质载体的局部麻醉和止痛作用。
Drug Deliv. 2021 Dec;28(1):478-486. doi: 10.1080/10717544.2021.1889717.
纳米脂质体包裹的麻醉剂用于局部麻醉应用。
Biomed Pharmacother. 2017 Feb;86:1-7. doi: 10.1016/j.biopha.2016.11.137. Epub 2016 Dec 6.
4
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.基于固体脂质纳米粒和纳米结构脂质载体的纳米疗法治疗银屑病的比较研究
Expert Opin Drug Deliv. 2017 Feb;14(2):165-177. doi: 10.1080/17425247.2017.1264386. Epub 2016 Dec 4.
5
How can lipid nanocarriers improve transdermal delivery of olanzapine?脂质纳米载体如何改善奥氮平的透皮给药?
Pharm Dev Technol. 2017 Jun;22(4):587-596. doi: 10.1080/10837450.2016.1200615. Epub 2016 Nov 23.
6
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.用于局部和透皮给药的脂质囊泡及微粒载体的最新进展
J Pharm Sci. 2017 Feb;106(2):423-445. doi: 10.1016/j.xphs.2016.10.001. Epub 2016 Nov 16.
7
Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry.纳米结构脂质载体作为牙科局部利多卡因-丙胺卡因释放的强大系统。
Eur J Pharm Sci. 2016 Oct 10;93:192-202. doi: 10.1016/j.ejps.2016.08.030. Epub 2016 Aug 16.
8
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.固体脂质纳米粒和纳米结构脂质载体的临床前安全性:来自体外和体内评价的当前证据
Eur J Pharm Biopharm. 2016 Nov;108:235-252. doi: 10.1016/j.ejpb.2016.08.001. Epub 2016 Aug 9.
9
Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice.壳聚糖-固体脂质纳米粒包裹的阿司匹林和姜黄素与游离萝卜硫素联合应用于BALB/c小鼠的临床前全身毒性评估
Int J Nanomedicine. 2016 Jul 20;11:3265-76. doi: 10.2147/IJN.S106736. eCollection 2016.
10
Effect of lipid nanoparticle formulations on skin delivery of a lipophilic substance.脂质纳米颗粒制剂对亲脂性物质皮肤递送的影响。
Eur J Pharm Biopharm. 2016 Nov;108:289-296. doi: 10.1016/j.ejpb.2016.07.016. Epub 2016 Jul 20.